The Brn-2 Transcription Factor Links Activated BRAF to Melanoma Proliferation

AUTOR(ES)

Goodall, Jane

FONTE

American Society for Microbiology

RESUMO

Malignant melanoma, an aggressive and increasingly common cancer, is characterized by a strikingly high rate (70%) of mutations in BRAF, a key component of the mitogen-activated protein (MAP) kinase signaling pathway. How signaling events downstream from BRAF affect the underlying program of gene expression is poorly understood. We show that the Brn-2 POU domain transcription factor is highly expressed in melanoma cell lines but not in melanocytes or melanoblasts and that overexpression of Brn-2 in melanocytes results in increased proliferation. Expression of Brn-2 is strongly upregulated by Ras and MAP kinase signaling. Importantly, the Brn-2 promoter is stimulated by kinase-activating BRAF mutants and endogenous Brn-2 expression is inhibited by RNA interference-mediated downregulation of BRAF. Moreover, silent interfering RNA-mediated depletion of Brn-2 in melanoma cells expressing activated BRAF leads to decreased proliferation. The results suggest that the high levels of Brn-2 expression observed in melanomas link BRAF signaling to increased proliferation.

Documentos Relacionados

• Brn-2 Expression Controls Melanoma Proliferation and Is Directly Regulated by β-Catenin
• Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons
• The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development
• The human Brn-3b POU transcription factor shows only limited homology to the Brn-3a/RDC-1 factor outside the conserved POU domain.
• Polymorphisms of the BRAF gene predispose males to malignant melanoma